Delivery Order SPE2DR25D3301-SPE2DR26F21NP
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 7, 2026, for the supply of Creon DR 36,000 Unit Capsules in quantities of 100s. This non-set-aside, competitively awarded contract carries a ceiling value of $4,054.87 with a firm fixed-price structure and an ultimate completion date of January 8, 2026. The product will be performed at the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 count units. This firm fixed-price delivery order carries a ceiling value of $2,223.33 and is scheduled for completion by November 26, 2025. The contract was competitively awarded with no set-aside designation, and performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,101.10 to AmerisourceBergen Drug Corp on July 24, 2025, for 12,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, carrying an ultimate completion date of July 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $9,788.44. This is a firm fixed price delivery order with an ultimate completion date of October 30, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made without a set-aside designation, indicating that AmerisourceBergen competed for this order on an open basis. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of 36,000 unit capsules of Creon (pancreatic enzyme supplement) in 100-count bottles, with a ceiling value of $1,452.16 and a completion date of January 15, 2026. This is a firm fixed-price, non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, valued at $4,258.00, with an ultimate completion date of December 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a discrete delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules valued at $2,554.80, with an ultimate completion date of December 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of 24,000 units of Creon DR 100s capsules, with a contract ceiling value of $8,378.86 and an ultimate completion date of January 23, 2026. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100S capsules, valued at $3,264.76, with an ultimate completion date of January 2, 2026. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single order fulfillment under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $15,277.83 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancrelipase) in 100-count packages. This is a firm fixed-price, non-set-aside contract with a completion date of January 16, 2026, issued on January 15, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...